These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 11709724

  • 1. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
    Bader AG, Schneider ML, Bister K, Hartl M.
    Oncogene; 2001 Nov 08; 20(51):7524-35. PubMed ID: 11709724
    [Abstract] [Full Text] [Related]

  • 2. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
    Hartl M, Reiter F, Bader AG, Castellazzi M, Bister K.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13601-6. PubMed ID: 11698665
    [Abstract] [Full Text] [Related]

  • 3. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
    Bader AG, Hartl M, Bister K.
    Virology; 2000 Apr 25; 270(1):98-110. PubMed ID: 10772983
    [Abstract] [Full Text] [Related]

  • 4. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M, Bister K.
    Oncogene; 1998 Dec 03; 17(22):2901-13. PubMed ID: 9879996
    [Abstract] [Full Text] [Related]

  • 5. Suppression in transformed avian fibroblasts of a gene (CO6) encoding a membrane protein related to mammalian potassium channel regulatory subunits.
    Oberst C, Weiskirchen R, Hartl M, Bister K.
    Oncogene; 1997 Mar 06; 14(9):1109-16. PubMed ID: 9070660
    [Abstract] [Full Text] [Related]

  • 6. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
    Chamboredon S, Briggs J, Vial E, Hurault J, Galvagni F, Oliviero S, Bos T, Castellazzi M.
    Oncogene; 2003 Jun 26; 22(26):4047-61. PubMed ID: 12821939
    [Abstract] [Full Text] [Related]

  • 7. TOJ3, a v-jun target with intrinsic oncogenic potential, is directly regulated by Jun via a novel AP-1 binding motif.
    Karagiannidis AI, Bader AG, Hartl M, Bister K.
    Virology; 2008 Sep 01; 378(2):371-6. PubMed ID: 18603277
    [Abstract] [Full Text] [Related]

  • 8. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
    Basso J, Briggs J, Findlay C, Bos T.
    Oncogene; 2000 Oct 05; 19(42):4876-85. PubMed ID: 11039905
    [Abstract] [Full Text] [Related]

  • 9. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
    Kilbey A, Black EJ, Unlu M, Gillespie DA.
    Oncogene; 1996 Jun 06; 12(11):2409-18. PubMed ID: 8649782
    [Abstract] [Full Text] [Related]

  • 10. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains.
    Weiskirchen R, Bister K.
    Oncogene; 1993 Sep 06; 8(9):2317-24. PubMed ID: 8361751
    [Abstract] [Full Text] [Related]

  • 11. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
    Hadman M, Loo M, Bos TJ.
    Oncogene; 1993 Jul 06; 8(7):1895-903. PubMed ID: 8510933
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
    Castellazzi M, Dangy JP, Mechta F, Hirai S, Yaniv M, Samarut J, Lassailly A, Brun G.
    Oncogene; 1990 Oct 06; 5(10):1541-7. PubMed ID: 2123532
    [Abstract] [Full Text] [Related]

  • 13. Differential and antagonistic effects of v-Jun and c-Jun.
    Gao M, Morgan I, Vogt PK.
    Cancer Res; 1996 Sep 15; 56(18):4229-35. PubMed ID: 8797597
    [Abstract] [Full Text] [Related]

  • 14. Identification and characterization of genes upregulated in cells transformed by v-Jun.
    Fu SL, Waha A, Vogt PK.
    Oncogene; 2000 Jul 20; 19(31):3537-45. PubMed ID: 10918612
    [Abstract] [Full Text] [Related]

  • 15. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S, Vial E, van Dam H, Castellazzi M.
    Oncogene; 2001 Mar 01; 20(9):1135-41. PubMed ID: 11314051
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E, Perez S, Castellazzi M.
    Oncogene; 2000 Oct 12; 19(43):5020-9. PubMed ID: 11042689
    [Abstract] [Full Text] [Related]

  • 17. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
    Morgan IM, Asano M, Håvarstein LS, Ishikawa H, Hiiragi T, Ito Y, Vogt PK.
    Oncogene; 1993 May 12; 8(5):1135-40. PubMed ID: 8479738
    [Abstract] [Full Text] [Related]

  • 18. HTRP--an immediate-early gene product induced by HSV1 infection in human embryo fibroblasts, is involved in cellular co-repressors.
    Li JF, Liu LD, Ma SH, Che YC, Wang LC, Dong CH, Zhao HL, Liao Y, Li QH.
    J Biochem; 2004 Aug 12; 136(2):169-76. PubMed ID: 15496587
    [Abstract] [Full Text] [Related]

  • 19. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
    Cohen SB, Waha A, Gelman IH, Vogt PK.
    Oncogene; 2001 Jan 11; 20(2):141-6. PubMed ID: 11313943
    [Abstract] [Full Text] [Related]

  • 20. A rearranged junD transforms chicken embryo fibroblasts.
    Hartl M, Vogt PK.
    Cell Growth Differ; 1992 Dec 11; 3(12):909-18. PubMed ID: 1472471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.